Immunome, Inc.IMNMNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank71
Studio
Year-over-Year Change

Return on equity

Latest
-33.48%
↑ 50% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-67.44%
Historical baseline
PeriodValueYoY Change
2025-33.48%+79.3%
2024-161.71%-81.5%
2023-89.09%+59.8%
2022-221.56%-332.0%
2021-51.28%-18.9%
2020-43.14%-245.7%
201929.61%-4.9%
201831.12%-